Bristol-Myers Squibb (BMY) Tops Q3 EPS by 26c, Beats on Revenue; Offers FY26 Guidance

Go back to Bristol-Myers Squibb (BMY) Tops Q3 EPS by 26c, Beats on Revenue; Offers FY26 Guidance

Bristol Myers Squibb Reports Third Quarter Financial Results for 2026

October 29, 2026 6:59 AM EDT

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE:... More